You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 6, 2025

Drug Price Trends for NDC 46122-0284


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 46122-0284

Drug Name NDC Price/Unit ($) Unit Date
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.23480 EACH 2024-12-18
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.21131 EACH 2024-11-20
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.26050 EACH 2024-10-23
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.22870 EACH 2024-09-18
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.24104 EACH 2024-08-21
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.19667 EACH 2024-07-17
GNP NICOTINE 2 MG CHEWING GUM 46122-0284-60 0.24965 EACH 2024-06-19
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 46122-0284

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

46122-0284 Market Analysis and Financial Projection

Market Analysis and Price Projections for Drug NDC: 46122-0284

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product. This code is essential for tracking and managing drug products in the pharmaceutical market[1][5].

NDC 46122-0284 Breakdown

  • Labeler Code: The first segment of the NDC, which identifies the firm that manufactures, repackages, or relabels the drug.
  • Product Code: The second segment, which identifies the specific strength, dosage form, and formulation of the drug.
  • Package Code: The third segment, which identifies the package size and type.

For the NDC 46122-0284, the labeler code is "46122," the product code is "028," and the package code is "4."

Market Context

Pharmaceutical Industry Trends

The pharmaceutical industry is undergoing significant changes driven by technological advancements, regulatory shifts, and evolving market dynamics. Key trends include the continued dominance of small molecule drugs, increasing adoption of biologics, and a growing demand for personalized medicine[3].

Drug Price Inflation

Drug price inflation is a critical factor in market analysis. According to Vizient, Inc., drug price inflation is projected to grow at 3.8% in 2024, driven largely by specialty pharmaceuticals. This includes drugs for high-cost, complex, or chronic conditions such as cancer, infectious diseases, autoimmune diseases, and pulmonary conditions[4].

Price Projections

Ceiling Price Calculations

For drugs participating in the Medicaid Drug Rebate Program (MDRP), the ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This price is then adjusted by the package size and case pack size to determine the final ceiling price[2].

To project the price for NDC 46122-0284, one would need to:

  • Determine if the drug participates in the MDRP.
  • Obtain the Average Manufacturer Price (AMP) and Unit Rebate Amount (URA) for the drug.
  • Calculate the ceiling price using the formula: ( \text{Ceiling Price} = (\text{AMP} - \text{URA}) \times \text{Package Size} \times \text{Case Pack Size} )[2].

Specialty Pharmaceuticals

Given that specialty pharmaceuticals are driving the increase in provider spending, if NDC 46122-0284 falls under this category, it is likely to see a price increase. Vizient projects a 4.18% price increase for specialty medications, which could impact the pricing of this drug[4].

Market Dynamics

Competition and Market Share

The market dynamics, including competition from biosimilars and other drugs in the same therapeutic class, can significantly impact price projections. For instance, biosimilars are expected to grow in market share, which could lead to pricing pressures on branded drugs[4].

Regulatory Environment

The regulatory environment, including FDA approvals and compliance with drug listing obligations, also plays a crucial role. Ensuring that the drug is listed in the NDC Directory and complies with all regulatory requirements is essential for its market presence[1][5].

Key Takeaways

  • NDC Understanding: The NDC is a critical identifier for drug products, helping in tracking and managing them.
  • Market Trends: The pharmaceutical industry is driven by trends such as the dominance of small molecule drugs, increasing adoption of biologics, and growing demand for personalized medicine.
  • Price Inflation: Drug price inflation, particularly for specialty pharmaceuticals, is expected to rise.
  • Ceiling Price Calculations: For drugs in the MDRP, ceiling prices are calculated based on AMP, URA, package size, and case pack size.
  • Market Dynamics: Competition from biosimilars and regulatory compliance are key factors influencing price projections.

FAQs

Q: What does the National Drug Code (NDC) represent? A: The NDC is a unique, three-segment number that identifies the labeler, product, and trade package size of a drug product.

Q: How is the ceiling price for a drug calculated under the Medicaid Drug Rebate Program? A: The ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusted by package size and case pack size.

Q: What are the key drivers of drug price inflation in 2024? A: Specialty pharmaceuticals, including weight loss drugs and gene therapies, are significant drivers of drug price inflation in 2024.

Q: How do biosimilars impact the pricing of branded drugs? A: Biosimilars can lead to pricing pressures on branded drugs as they gain market share, potentially reducing the prices of the original branded drugs.

Q: Why is regulatory compliance important for drug pricing? A: Regulatory compliance ensures that the drug is listed in the NDC Directory and meets all FDA requirements, which is essential for its market presence and pricing stability.

Sources

  1. FDA: National Drug Code Database Background Information.
  2. HRSA: NDC Product Details.
  3. Global Pharma Tek: Top 12 Pharmaceutical Industry Trends in 2024.
  4. Vizient, Inc.: Vizient Projects 3.8% Drug Price Increase Driven by Specialty Pharmaceuticals.
  5. FDA: National Drug Code Directory.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.